Key points are not available for this paper at this time.
Background . Recent research has established the existence of epigenetic modulation of the immune response. The possible involvement of RNA‐n6‐methyladenosine (m 6 A) alteration in tumor microenvironment (TME) cell invasion, on the other hand, is unknown. Methods . Based on 23 m 6 A regulators, we examined the alteration patterns of m 6 A in 629 LUAD tissues and comprehensively connected these modification patterns with TME cell invasion characteristics. The m 6 A score was calculated, and the m 6 A modification pattern of a single tumor was quantified using principal component analysis. Then, we further verified the expression of m 6 A related enzymes and the role hub gene (NOL10) closely related to survival in lung cancer cell lines. Results . Three separate m 6 A alteration modes have been discovered. TME cell invasion characteristics in the three modes were very similar to the three immunological phenotypes of tumors: immunological rejection, immunological inflammation, and immunological desert. We show that assessing the m 6 A modification pattern in a single tumor may help predict tumor inflammatory stage, subtype, TME interstitial activity, and prognosis. TME phenotypic inflammation is indicated by a high m 6 A score, which is characterized by elevated mutation load and immunological activation. The low m 6 A subtype showed matrix activation and ineffective immune infiltration, indicating that the TME phenotype of noninflammation and immunological rejection had a poor survival probability. Increased neoantigen burden was also linked to a high m 6 A score. Patients with a higher m 6 A score saw substantial therapeutic and clinical improvements. And reducing hub gene NOL10 expression substantially inhibited lung cancer cell growth and migration. Conclusions . This research shows that m 6 A alteration is critical in the creation of TME variety and complexity. The analysis of a single tumor’s m 6 A alteration pattern will aid in improving our knowledge of TME invasion features and guiding more effective immunotherapy tactics.
Jiang et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: